Sitomni-M-OD 100/500

Sitomni-M-OD 100/500 by EMK Omni Pharma is a prescription medicine that combines Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg with Metformin Hydrochloride IP 500 mg in a single film-coated tablet designed for once-daily (OD) use. Sitagliptin is a DPP-4 inhibitor that helps the body raise insulin levels after meals and lower glucagon, while Metformin reduces glucose production by the liver and improves how the body responds to insulin. Together they support blood sugar control in adults with type 2 diabetes mellitus whose glucose is not adequately controlled by a single agent.

Sitomni-M-OD 100/500 may be prescribed by physicians for patients who need a convenient once-daily combination as part of a doctor-supervised diabetes care plan that also includes diet and exercise. It belongs to the anti-diabetic pharmaceutical category and must be taken only as directed by a registered medical practitioner. Patients should swallow the tablet whole without chewing or crushing, should not self-medicate or alter the dose, and should attend regular blood-sugar and kidney-function check-ups as advised by their doctor.